HomeNewsBusinessBuy Polycab, India; target of Rs 2197: Anand Rathi

Buy Polycab, India; target of Rs 2197: Anand Rathi

Anand Rathi is bullish on Polycab, India has recommended buy rating on the stock with a target price of Rs 2197 in its research report dated July 22, 2021.

July 23, 2021 / 12:43 IST
Story continues below Advertisement
An Edelweiss research report for Q4FY21 says road tonnage continued to improve, evident in e-way bill generation (up 6% QoQ) and improved core trucking rentals. “We estimate tonnage would increase by three–five percent for truckers. Asset-light plays Mahindra Logistics and TCI Express remain our preferred picks due to their ability to scale up/down as the environment demands,” the report said. Edelweiss is bullish on Blue Dart Express due to the pandemic-induced boom in e-commerce and its leaner cost structure. It has retained a ‘buy’ call on Mahindra Logistics, TCI Express and Blue Dart Express.
An Edelweiss research report for Q4FY21 says road tonnage continued to improve, evident in e-way bill generation (up 6% QoQ) and improved core trucking rentals. “We estimate tonnage would increase by three–five percent for truckers. Asset-light plays Mahindra Logistics and TCI Express remain our preferred picks due to their ability to scale up/down as the environment demands,” the report said. Edelweiss is bullish on Blue Dart Express due to the pandemic-induced boom in e-commerce and its leaner cost structure. It has retained a ‘buy’ call on Mahindra Logistics, TCI Express and Blue Dart Express.

Anand Rathi's research report on Polycab, India

Polycab’s management sees the weaker-than-anticipated Q1 as a blip, and drivers of long-term growth intact. Rising infra spend, export opportunities and its expansion to adjacent categories would drive its B2B portfolio. A 25%+ revenue CAGR and margin expansion in FMEG would continue. It will elaborate next quarter on its vision of over Rs200bn revenue by FY26 (implied CAGR: 18%). We are optimistic on Polycab’s prospects and expect 24%/23% CAGRs in revenue/PAT over FY21-23 with the RoE nearing 20% and healthy FCF continuing.

Story continues below Advertisement

Outlook